SAREPTA THERAPEUTICS INC - DBCV 1.500%11/1

Historical Portfolio Holders from Q4 2018 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Debt / DBCV 1.500%11/1
Principal, excl. options Q1 2024
62 M
Holdings value Q1 2024
$111 M
Value change Q1 2024
-$733 K
Grand Portfolio weight change Q1 2024
0%
Number of holders
17
Number of buys Q1 2024
5
Number of sells Q1 2024
-7
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
803607AB6
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q1 $62 M $111 M -$733 K $1.79 17
2023 Q4 $63 M $89.3 M -$2.41 M $1.42 21
2023 Q3 $63.4 M $113 M +$749 K $1.77 20
2023 Q2 $63.6 M $108 M +$10.2 M $1.69 23
2023 Q1 $55.6 M $108 M -$498 M $1.93 23
2022 Q4 $321 M $600 M +$3.46 M $1.87 37
2022 Q3 $373 M $551 M -$125 M $1.67 35
2022 Q2 $512 M $532 M -$50.8 M $1.26 34
2022 Q1 $549 M $605 M -$111 M $1.31 36
2021 Q4 $545 M $799 M +$1.34 M $1.46 35
2021 Q3 $547 M $812 M +$10.4 M $1.48 43
2021 Q2 $540 M $722 M -$10.7 M $1.32 42
2021 Q1 $552 M $725 M -$91.6 M $1.31 41
2020 Q4 $528 M $1.28 B +$16.3 M $2.45 46
2020 Q3 $524 M $1.07 B +$38.1 M $2.07 43
2020 Q2 $508 M $1.15 B +$13.5 M $2.30 45
2020 Q1 $518 M $765 M +$4.35 M $1.52 41
2019 Q4 $513 M $971 M +$15.7 M $1.95 39
2019 Q3 $539 M $685 M +$23.7 M $1.32 38
2019 Q2 $500 M $1.06 B -$30.1 M $2.23 41
2019 Q1 $521 M $893 M +$814 M $1.80 39
2018 Q4 $44.1 M $73.9 M +$73.9 M $1.68 1